Brentuximab vedotin and AVD chemotherapy followed by ISRT: A safe primary treatment regimen for early-stage, unfavorable Hodgkin lymphoma Meeting Abstract
| Authors: | Yang, J. C.; Kumar, A.; Chapman, K. L.; Constine, L. S.; Moskowitz, C. H.; Yahalom, J. |
| Abstract Title: | Brentuximab vedotin and AVD chemotherapy followed by ISRT: A safe primary treatment regimen for early-stage, unfavorable Hodgkin lymphoma |
| Meeting Title: | 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 96 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2016 Sep 25-28 |
| Meeting Location: | Boston, MA |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-10-01 |
| Start Page: | S21 |
| Language: | English |
| ACCESSION: | WOS:000387655804382 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2016.06.064 |
| Notes: | Meeting Abstract: 45 -- 58th Annual Meeting of the American-Society-for-Radiation-Oncology -- SEP 25-28, 2016 -- Boston, MA -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
